Nesina 6.25 mg (Alogliptin (Alogliptin Benzoate) TABLET) 6.25 MG

Nesina 6.25 mg tablets contain alogliptin (alogliptin benzoate), a medication used to manage blood sugar levels in adults with type 2 diabetes. This oral tablet is designed to be taken as part of a comprehensive diabetes management plan.

Strength

6.25 MG

Pack Size

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nesina 6.25 mg tablets are primarily used to help control blood sugar levels in adults with type 2 diabetes. This medication works by increasing the levels of incretin hormones, which help the pancreas release insulin in response to meals. It is often used alongside diet and exercise to manage diabetes effectively. People often ask, 'What is Nesina used for?' and the answer is that it is used to improve glycemic control in adults with type 2 diabetes.

Side Effects

Common effects of Nesina 6.25 mg tablets may include headache, nasal congestion, and upper respiratory tract infection. Some individuals might experience gastrointestinal issues such as nausea or diarrhea. These effects vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Nesina 6.25 mg tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. Patients with a history of pancreatitis or severe kidney problems should discuss their medical history with a healthcare professional before starting this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

Nesina 6.25 mg tablets may interact with certain medications, including other diabetes drugs, CYP inhibitors, and some antibiotics. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect blood sugar levels.

Frequently Asked Questions

Nesina 6.25 mg tablets are used to help manage blood sugar levels in adults with type 2 diabetes.

Nesina 6.25 mg tablets are taken orally, usually once daily, with or without food.

Common side effects may include headache, nasal congestion, and upper respiratory tract infection.

Nesina may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Nesina should be used with caution in individuals with a history of pancreatitis or severe kidney problems.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.